Skip to main content
. 2019 Apr 19;19(2):191–200. doi: 10.1007/s40268-019-0270-3

Table 3.

Severity grading of common cold symptoms at screening (study 2)

Symptom Severity 0.5% Carbomer 980 gel nasal spray (n = 87) Placebo nasal spray (n = 81)
Runny nose Mild 23 (26.4) 15 (18.5)
Moderate 44 (50.6) 43 (53.1)
Severe 14 (16.1) 20 (24.7)
Absent 6 (6.9) 3 (3.7)
Blocked nose Mild 13 (14.9) 12 (14.8)
Moderate 43 (49.4) 40 (49.4)
Severe 23 (26.4) 21 (25.9)
Absent 8 (9.2) 8 (9.9)
Sneezing Mild 23 (26.4) 32 (39.5)
Moderate 41 (47.1) 32 (39.5)
Severe 10 (11.5) 13 (16.0)
Absent 13 (14.9) 4 (4.9)
Headache Mild 34 (39.1) 17 (21.0)
Moderate 25 (28.7) 30 (37.0)
Severe 10 (11.5) 7 (8.6)
Absent 18 (20.7) 27 (33.3)
Muscle aches Mild 28 (32.2) 26 (32.1)
Moderate 23 (26.4) 23 (28.4)
Severe 8 (9.2) 12 (14.8)
Absent 28 (32.2) 20 (24.7)
Chills Mild 25 (28.7) 25 (30.9)
Moderate 23 (26.4) 20 (24.7)
Severe 9 (10.3) 4 (4.9)
Absent 30 (34.5) 32 (39.5)
Sore throat Mild 23 (26.4) 20 (24.7)
Moderate 35 (40.2) 37 (45.7)
Severe 15 (17.2) 16 (19.8)
Absent 14 (16.1) 8 (9.9)
Cough Mild 14 (16.1) 21 (25.9)
Moderate 46 (52.9) 41 (50.6)
Severe 22 (25.3) 17 (21.0)
Absent 5 (5.7) 2 (2.5)